Skila’s Susan Dorfman Named in 2008 PharmaVoice 100
Morris Plains, NJ, July 28, 2008 – Skila congratulates Susan Dorfman, VP of Global Marketing, for being named in the 2008 PharmaVoice 100 as a “Brand Champion with the strategic know-how, market insights, and a creative flair that differentiates their products from the competition.”
Since joining Skila in 2007, Ms. Dorfman’s innovative ideas, strategic thinking and out-of-the-box marketing tactics have enabled Skila to reap the benefits of quickly generating broad global awareness, recognition, trial and advocacy. The July/August issue of PharmaVoice honors Ms. Dorfman as “a highly energetic and driven professional with a razor-sharp understanding of the pharmaceutical industry and the changing trends that are affecting companies and brands today. Passionate about her work, Ms. Dorfman can always be counted on to come up with a forward strategy backed by innovative ideas. She exemplifies the type of leader who always challenges herself with long-term visionary goals and continuously demonstrates an unselfish dedication to her team, company, and clients.”
“Susan’s involvement in defining market strategy and working closely with sales and product management has had a tremendous impact on Skila’s bottom line,” says Moish Tov, Skila’s CEO.
“Susan is an inspiration and always has time to help others in the organization. Her contributions to Skila know no bounds and she is as likely to get involved in a brainstorming session with product development as she is to debate the merits of one message vs. another.” says Sara Melo-Pereira, Director of Global Marketing. “I’m lucky to have such a great mentor in my professional career and be able to call her a friend as well.”
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients.
